NPR3 Knockout HeLa Cell Line
Cat.No.:
EDC90131
Species:
Human
Cell Name:
HeLa
Gene:
NPR3
Gene ID:
4883
Size:
1×10⁶cells
NPR3 Knockout Cell Line (Hela) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90131 |
|---|---|
| Product Name | NPR3 Knockout HeLa Cell Line |
| Cell Line | HeLa |
| Cellosaurus ID | CVCL_0030 |
| Cell Line Synonyms | HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
| Gene | NPR3 |
| NCBI Gene ID | |
| Gene Synonyms | ANP-C|ANPR-C|ANPRC|BOMOS|C5orf23|GUCY2B|NPR-C|NPRC |
| Summary |
This gene encodes one of three natriuretic peptide receptors. Natriutetic peptides are small peptides which regulate blood volume and pressure, pulmonary hypertension, and cardiac function as well as some metabolic and growth processes. The product of this gene encodes a natriuretic peptide receptor responsible for clearing circulating and extracellular natriuretic peptides through endocytosis of the receptor. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
|
| Associated Diseases | Cervical Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5, 2days |
| Complete Culture Medium | MEM + 10% FBS |
| Freezing Medium | 70%Complete culture medium+ 20% FBS+ 10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HeLa | STR Info (Cell bank) Cell Line: HeLa | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 9 | 10 | 9 | 10 |
| D1S1656 | 12 | 15 | 12 | 15 |
| D2S1338 | 17 | 17 | ||
| D3S1358 | 15 | 18 | 15 | 18 |
| D5S818 | 11 | 12 | 11 | 12 |
| D6S1043 | 18 | 18 | ||
| D7S820 | 8 | 12 | 8 | 12 |
| D8S1179 | 12 | 13 | 12 | 13 |
| D12S391 | 20 | 25 | 20 | 25 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 10 | 9 | 10 |
| D18S51 | 16 | 16 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 27 | 28 | 27 | 28 |
| FGA | 18 | 21 | 18 | 21 |
| Penta D | 8 | 15 | 8 | 15 |
| Penta E | 7 | 17 | 7 | 17 |
| TPOX | 8 | 12 | 8 | 12 |
| VWA | 16 | 18 | 16 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying NPR3 function, NPR3 Knockout HeLa Cell Line or NPR3 overexpression HeLa Cell Line?
The choice depends on whether you are studying NPR3 (NPR-C)'s role as the natriuretic peptide clearance receptor or its emerging functions in signaling distinct from clearance. The Knockout line is the standard tool for asking whether NPR-C is required for clearing ANP, BNP, and CNP from circulation — NPR-C lacks guanylyl cyclase activity and primarily internalizes/degrades natriuretic peptides, regulating their bioavailability. Overexpression is useful for studying NPR-C signaling functions or for testing NPR-C-selective ligand specificity.
For natriuretic peptide research, the EDITGENE NPR3 Knockout in HeLa enables study of clearance-deficient natriuretic peptide signaling. This product complements the parallel NPR1 and NPR2 Knockouts in HeLa (also available); the NPR3 KO is unique in that loss enhances ANP/BNP/CNP signaling by reducing clearance. Rescue with wild-type or clearance-deficient NPR-C is the standard specificity control.
What are the application scenarios for this model?
Primary applications:
• Natriuretic peptide clearance: ¹²⁵I-ANP, ¹²⁵I-BNP, or ¹²⁵I-CNP cellular uptake assays in NPR3-null cells to quantify NPR-C-dependent clearance.
• Enhanced NP signaling: assessment of ANP/BNP/CNP-induced cGMP and downstream effects in the NPR3-null context, where clearance is impaired.
• NPR-C signaling studies: Gi-coupled signaling readouts given NPR-C's reported signaling functions distinct from clearance.
• Pharmaceutical NP analog studies: testing of clearance-resistant NP analogs (e.g., carperitide, BD-CNP) in NPR3-null cells.
EDITGENE recommends this model for researchers investigating natriuretic peptide clearance and NPR-C signaling biology.
Is this NPR3 Knockout HeLa Cell Line compatible with overexpression rescue experiments?
Yes. NPR-C rescue experiments require attention to receptor topology:
• Construct design: use a codon-modified NPR3 sequence with a small intracellular C-terminal tag (FLAG, HA). NPR-C has extracellular natriuretic peptide-binding domain, single transmembrane span, and short intracellular C-terminus — NPR-C lacks guanylyl cyclase activity.
• Internalization-deficient rescue: cytoplasmic tail mutations may affect internalization/clearance without affecting binding.
• Functional readout: rescue should restore natriuretic peptide clearance (¹²⁵I-NP uptake) and reduce ambient ANP/BNP/CNP levels.
HeLa transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download